Literature DB >> 34197833

Small Molecule Sequestration of the Intrinsically Disordered Protein, p27Kip1, Within Soluble Oligomers.

Luigi I Iconaru1, Sourav Das2, Amanda Nourse3, Anang A Shelat2, Jian Zuo4, Richard W Kriwacki5.   

Abstract

Proteins that exhibit intrinsically disordered regions (IDRs) are prevalent in the human proteome and perform diverse biological functions, including signaling and regulation. Due to these important roles, misregulation of intrinsically disordered proteins (IDPs) is associated with myriad human diseases, including neurodegeneration and cancer. The inherent flexibility of IDPs limits the applicability of the traditional structure-based drug design paradigm; therefore, IDPs have long been considered "undruggable". Using NMR spectroscopy and other methods, we previously discovered small, drug-like molecules that bind specifically, albeit weakly, to dynamic clusters of aromatic residues within p27Kip1 (p27), an archetypal disordered protein involved in cell cycle regulation. Here, using synthetic chemistry, NMR spectroscopy and other biophysical methods, we discovered elaborated analogs of our previously reported molecules with 30-fold increased affinity for p27 (apparent Kd = 57 ± 19 μM). Strikingly, using analytical ultracentrifugation methods, we showed that the highest affinity compounds caused p27 to form soluble, disordered oligomers. Based on these observations, we propose that sequestration within soluble oligomers may represent a general strategy for therapeutically targeting disease-associated IDPs in the future.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AUC; Fragment-based drug discovery; Hit to lead optimization; Intrinsically disordered proteins; NMR

Mesh:

Substances:

Year:  2021        PMID: 34197833      PMCID: PMC8658733          DOI: 10.1016/j.jmb.2021.167120

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   6.151


  32 in total

1.  Macromolecular size-and-shape distributions by sedimentation velocity analytical ultracentrifugation.

Authors:  Patrick H Brown; Peter Schuck
Journal:  Biophys J       Date:  2006-03-24       Impact factor: 4.033

2.  Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain.

Authors:  P H Kussie; S Gorina; V Marechal; B Elenbaas; J Moreau; A J Levine; N P Pavletich
Journal:  Science       Date:  1996-11-08       Impact factor: 47.728

3.  Overview of current methods in sedimentation velocity and sedimentation equilibrium analytical ultracentrifugation.

Authors:  Huaying Zhao; Chad A Brautigam; Rodolfo Ghirlando; Peter Schuck
Journal:  Curr Protoc Protein Sci       Date:  2013-02

Review 4.  Function and dysfunction of α-synuclein: probing conformational changes and aggregation by single molecule fluorescence.

Authors:  Adam J Trexler; Elizabeth Rhoades
Journal:  Mol Neurobiol       Date:  2012-09-16       Impact factor: 5.590

5.  Tight regulation of unstructured proteins: from transcript synthesis to protein degradation.

Authors:  Jörg Gsponer; Matthias E Futschik; Sarah A Teichmann; M Madan Babu
Journal:  Science       Date:  2008-11-28       Impact factor: 47.728

6.  p27 binds cyclin-CDK complexes through a sequential mechanism involving binding-induced protein folding.

Authors:  Eilyn R Lacy; Igor Filippov; William S Lewis; Steve Otieno; Limin Xiao; Sonja Weiss; Ludger Hengst; Richard W Kriwacki
Journal:  Nat Struct Mol Biol       Date:  2004-03-14       Impact factor: 15.369

Review 7.  Classification of intrinsically disordered regions and proteins.

Authors:  Robin van der Lee; Marija Buljan; Benjamin Lang; Robert J Weatheritt; Gary W Daughdrill; A Keith Dunker; Monika Fuxreiter; Julian Gough; Joerg Gsponer; David T Jones; Philip M Kim; Richard W Kriwacki; Christopher J Oldfield; Rohit V Pappu; Peter Tompa; Vladimir N Uversky; Peter E Wright; M Madan Babu
Journal:  Chem Rev       Date:  2014-04-29       Impact factor: 60.622

8.  Targeting the intrinsically disordered structural ensemble of α-synuclein by small molecules as a potential therapeutic strategy for Parkinson's disease.

Authors:  Gergely Tóth; Shyra J Gardai; Wagner Zago; Carlos W Bertoncini; Nunilo Cremades; Susan L Roy; Mitali A Tambe; Jean-Christophe Rochet; Celine Galvagnion; Gaia Skibinski; Steven Finkbeiner; Michael Bova; Karin Regnstrom; San-San Chiou; Jennifer Johnston; Kari Callaway; John P Anderson; Michael F Jobling; Alexander K Buell; Ted A Yednock; Tuomas P J Knowles; Michele Vendruscolo; John Christodoulou; Christopher M Dobson; Dale Schenk; Lisa McConlogue
Journal:  PLoS One       Date:  2014-02-14       Impact factor: 3.240

9.  Structure-based Inhibitor Design for the Intrinsically Disordered Protein c-Myc.

Authors:  Chen Yu; Xiaogang Niu; Fan Jin; Zhirong Liu; Changwen Jin; Luhua Lai
Journal:  Sci Rep       Date:  2016-03-02       Impact factor: 4.379

10.  Tau protein liquid-liquid phase separation can initiate tau aggregation.

Authors:  Susanne Wegmann; Bahareh Eftekharzadeh; Katharina Tepper; Katarzyna M Zoltowska; Rachel E Bennett; Simon Dujardin; Pawel R Laskowski; Danny MacKenzie; Tarun Kamath; Caitlin Commins; Charles Vanderburg; Allyson D Roe; Zhanyun Fan; Amandine M Molliex; Amayra Hernandez-Vega; Daniel Muller; Anthony A Hyman; Eckhard Mandelkow; J Paul Taylor; Bradley T Hyman
Journal:  EMBO J       Date:  2018-02-22       Impact factor: 11.598

View more
  2 in total

Review 1.  Liquid-liquid phase separation in tumor biology.

Authors:  Xuhui Tong; Rong Tang; Jin Xu; Wei Wang; Yingjun Zhao; Xianjun Yu; Si Shi
Journal:  Signal Transduct Target Ther       Date:  2022-07-08

Review 2.  Modulating biomolecular condensates: a novel approach to drug discovery.

Authors:  Diana M Mitrea; Matthäus Mittasch; Beatriz Ferreira Gomes; Isaac A Klein; Mark A Murcko
Journal:  Nat Rev Drug Discov       Date:  2022-08-16       Impact factor: 112.288

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.